Tofacitinib citrate is a salt form of tofacitinib, an active pharmaceutical ingredient used as an immunosuppressant. It is supplied as a pharmaceutical raw material for manufacturing purposes.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Tofacitinib citrate?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Tofacitinib
pharmaceutical raw material
3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanamide
pharmaceutical intermediate
L-carnitine
pharmaceutical raw material
Pentamethonium bromide
pharmaceutical raw material
Benzphetamine hydrochloride
pharmaceutical raw material
Butinoline phosphate
pharmaceutical raw material
(3S,4S)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-beta-oxo-1-piperidinepropanenitrile
pharmaceutical raw material
N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine hydrochloride
pharmaceutical raw material
The international HS code for Tofacitinib citrate (CAS 540737-29-9) is 2933.59.
2933.59
2933 59 95
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
2-hydroxypropane-1,2,3-tricarboxylic acid;3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile
SYIKUFDOYJFGBQ-YLAFAASESA-N
C[C@@H]1CCN(C[C@@H]1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N.C(C(=O)O)C(CC(=O)O)(C(=O)O)O
Sourcing Tofacitinib citrate?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.